Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.36B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$353M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$334M |
| 4 |
JPMorgan Chase
JPM
|
+$251M |
| 5 |
Amazon
AMZN
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$713M |
| 2 |
Invesco WilderHill Clean Energy ETF
PBW
|
+$508M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$474M |
| 4 |
Tesla
TSLA
|
+$460M |
| 5 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$363M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.39% |
| 2 | Financials | 8.32% |
| 3 | Consumer Discretionary | 6.71% |
| 4 | Healthcare | 6.14% |
| 5 | Communication Services | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
PUT
HCA Healthcare
HCA
$88.4B
| $4.71M | ﹤0.01% |
25,000
+8,600
| +52% | +$1.52M |
|
1802
ACI Worldwide
ACIW
$6.12B
| $4.69M | ﹤0.01% |
123,251
-33,275
| -21% | -$1.31M |
|
1803
First American
FAF
$7.98B
| $4.67M | ﹤0.01% |
82,394
+27,378
| +50% | +$1.49M |
|
1804
Takeda Pharmaceutical
TAK
$56.7B
| $4.67M | ﹤0.01% |
255,623
-36,926
| -13% | -$664K |
|
1805
CALL
Prologis
PLD
$136B
| $4.66M | ﹤0.01% |
44,000
+42,400
| +2,650% | +$4.32M |
|
|
LHCG
1806
DELISTED
LHC Group LLC
LHCG
| $4.66M | ﹤0.01% |
24,378
+3,268
| +15% | +$654K |
|
1807
Lamar Advertising Co
LAMR
$16.7B
| $4.66M | ﹤0.01% |
49,589
+11,909
| +32% | +$1.05M |
|
1808
Inovio Pharmaceuticals
INO
$85.6M
| $4.66M | ﹤0.01% |
41,821
+31,773
| +316% | +$4.18M |
|
1809
Banco Santander
SAN
$191B
| $4.66M | ﹤0.01% |
1,357,374
+141,152
| +12% | +$478K |
|
1810
Ralph Lauren
RL
$22.4B
| $4.66M | ﹤0.01% |
37,801
-5,471
| -13% | -$624K |
|
1811
Flowers Foods
FLO
$1.58B
| $4.64M | ﹤0.01% |
195,202
-15,064
| -7% | -$343K |
|
1812
Veracyte
VCYT
$4.45B
| $4.64M | ﹤0.01% |
86,359
+69,665
| +417% | +$4.01M |
|
1813
CALL
Canadian National Railway
CNI
$78.5B
| $4.64M | ﹤0.01% |
40,000
+38,900
| +3,536% | +$4.32M |
|
1814
Louisiana-Pacific
LPX
$5.14B
| $4.64M | ﹤0.01% |
83,691
+2,226
| +3% | +$101K |
|
1815
Bausch Health
BHC
$1.75B
| $4.64M | ﹤0.01% |
146,279
-292,706
| -67% | -$8.59M |
|
1816
Domo
DOMO
$171M
| $4.63M | ﹤0.01% |
82,288
+53,489
| +186% | +$3.47M |
|
|
ESPR
1817
DELISTED
Esperion Therapeutics
ESPR
| $4.63M | ﹤0.01% |
165,031
+153,969
| +1,392% | +$4.54M |
|
|
TGI
1818
DELISTED
Triumph Group
TGI
| $4.62M | ﹤0.01% |
251,433
-108,436
| -30% | -$1.62M |
|
1819
State Street SPDR S&P Metals & Mining ETF
XME
$3.75B
| $4.62M | ﹤0.01% |
115,741
-888,954
| -88% | -$32.7M |
|
1820
Editas Medicine
EDIT
$399M
| $4.62M | ﹤0.01% |
109,881
+69,228
| +170% | +$3.94M |
|
1821
MasTec
MTZ
$22.7B
| $4.62M | ﹤0.01% |
49,250
-76,710
| -61% | -$6.56M |
|
1822
CONMED
CNMD
$1.3B
| $4.61M | ﹤0.01% |
35,306
+20,733
| +142% | +$2.5M |
|
1823
AMN Healthcare
AMN
$1.35B
| $4.6M | ﹤0.01% |
62,454
+2,196
| +4% | +$163K |
|
1824
Twist Bioscience
TWST
$5.32B
| $4.59M | ﹤0.01% |
37,080
-36,838
| -50% | -$5.59M |
|
|
BHVN
1825
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $4.59M | ﹤0.01% |
67,163
+52,320
| +352% | +$4.23M |
|
Similar funds
Citigroup's Q1 2021 Portfolio in Review
As of Q1 2021, Citigroup held 7,934 positions worth $155B, down 8.7% from $169B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Citigroup withdrew a net $23.7B in Q1 2021, closing 1,718 positions and reducing 2,980 holdings. Its most notable exit was PARSLEY ENERGY INC, an estimated $102M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 10% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citigroup opened a new position in ProShares UltraPro Short QQQ worth $176M.
- Citigroup's largest Q1 2021 buy was ProShares UltraPro Short QQQ: 107,444 shares worth $176M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q1 2021, an estimated $1.36B increase.
- Citigroup's biggest Q1 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $713M.
- Citigroup fully exited PARSLEY ENERGY INC in Q1 2021, selling an estimated $102M.
- Citigroup's ten largest holdings make up 21% of its $155B portfolio in Q1 2021.
- Citigroup opened 527 new positions and closed 1,718 in Q1 2021.
- Citigroup's portfolio value fell 8.7% quarter-over-quarter to $155B.
Based on Citigroup's 13F filing for Q1 2021, filed 13 May 2021.